Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: A multivariable Mendelian randomisation analysis.
Richardson TG, Sanderson E, Palmer TM, Ala-Korpela M, Ference BA, Davey Smith G, Holmes MV. · 2020
Read Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: A multivariable Mendelian randomisation analysis. by Richardson TG, Sanderson E, Palmer TM, Ala-Korpela M, Ference BA, Davey Smith G, Holmes MV. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7089422.txt.
Description
Richardson and co-authors use genetics to ask which blood lipids really cause coronary heart disease. Their study appeared in PLoS Medicine. They ran a genome study in UK Biobank, then applied Mendelian randomisation with data on 60,801 heart disease cases and 123,504 controls.
Taken alone, LDL cholesterol, triglycerides, and apolipoprotein B each linked to higher risk. When the traits were judged together, only apolipoprotein B kept a strong effect. Higher HDL cholesterol and apolipoprotein A-I looked protective alone, but faded once apolipoprotein B was counted. The authors argue that apolipoprotein B best captures the harm from these particles. Readers get a clear case for focusing drug targets and tests on that measure.
Catalog record
| CREATOR | Richardson TG, Sanderson E, Palmer TM, Ala-Korpela M, Ference BA, Davey Smith G, Holmes MV. |
|---|---|
| YEAR | 2020 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 75 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |